Biocatalytic Reductive Amination- Discovery to Commercial Manufacturing applied to Abrocitinib JAK1 inhibitor

Post time 2024-4-29 17:32:13

journal：

Authors：Rajesh Kumar; Michael Karmilowicz; Dylan Burke; Michael Burns; Leslie Clark; Christina Connor; Eric Cordi; Nga Do; Kevin Doyle; Steve Hoagland; Chad Lewis; David Mangan; Carlos Martinez; Emma McInturff; Kevin Meldrum; Robert Pearson; Jeremy Steflik; Anil Rane; John Weaver

Published date：--

DOI：10.21203/rs.3.rs-244144/v1

PDF link：https://www.researchsquare.com/article/rs-244144/v1

Article link：http://dx.doi.org/10.21203/rs.3.rs-244144/v1

Article Source：Research Square Platform LLC。

Remark：

Post time 2024-4-29 17:32:14

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] Biocatalytic Reductive Amination- Discovery to Commercial Manufacturing applied to Abrocitinib JAK1 inhibitor

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Biocatalytic Reductive Amination- Discovery to Commercial Manufacturing applied to Abrocitinib JAK1 inhibitor Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Biocatalytic Reductive Amination- Discovery to Commercial Manufacturing applied to Abrocitinib JAK1 inhibitor